Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2010
09/07/2010CA2450871C Assay for identifying inhibitors of hiv rt dimerization
09/07/2010CA2231774C Plants which synthesize a modified starch, process for the production thereof and modified starch
09/07/2010CA2179895C Marker for pathologies comprising an auto-immune reaction and/or for inflammatory diseases
09/02/2010WO2010099536A2 Engineered proteins with high affinity for dota chelates
09/02/2010WO2010099205A1 Methods for treating progressive multifocal leukoencephalopathy (pml)
09/02/2010WO2010099186A1 Her2 antibody compositions
09/02/2010WO2010099153A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
09/02/2010WO2010099079A1 Antibodies to troponin i and methods of use thereof
09/02/2010WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010WO2010098781A1 Sphingosine 1-phosphate antagonism
09/02/2010WO2010098682A1 Cell marker for melanocyte lineage and cancer cells and uses thereof
09/02/2010WO2010097597A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010WO2010097437A1 Method for producing antibodies
09/02/2010WO2010097435A1 Method for producing antibodies
09/02/2010WO2010097394A1 Multivalent and/or multispecific rankl-binding constructs
09/02/2010WO2010097386A1 Antigen-binding constructs
09/02/2010WO2010097385A1 Antigen-binding constructs
09/02/2010WO2010097012A1 ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
09/02/2010WO2010096941A1 Methods for identifying immunobinders of cell-surface antigens
09/02/2010WO2010096930A1 Single chain antibodies for targeting pancreatic alpha and beta cells
09/02/2010WO2010075548A3 Immunoglobulin variants with altered binding to protein a
09/02/2010WO2010066914A3 Remedies for pemphigus containing anti fas ligand antibodies
09/02/2010WO2010063138A8 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof
09/02/2010WO2010047509A9 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same
09/02/2010WO2010042815A3 Vhh antibody fragments for use in the detection and treatment of cancer
09/02/2010WO2010006772A8 Use of cd95 inhibitors for the treatment of inflammatory disorders
09/02/2010WO2009089062A8 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
09/02/2010WO2009039639A8 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate
09/02/2010WO2008136694A9 Engineered rabbit antibody variable domains and uses thereof
09/02/2010US20100223684 Humanin receptor or humanin-like polypeptide receptor
09/02/2010US20100223678 protein isoforms of the pif-family and uses thereof
09/02/2010US20100222557 Cytokine zalpha11ligand antibodies
09/02/2010US20100222556 Antibodies to cytokine receptor zalpha11
09/02/2010US20100222555 Monoclonal antibodies that neutralize botulinum neurotoxin
09/02/2010US20100222411 Vhz for diagnosis and treatment of cancer
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100221844 Caustic stable chromatography ligands
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221770 Methods for Detecting and Analyzing N-Glycolylneuraminic Acid (Neu5Gc) In Biological Materials
09/02/2010US20100221749 Three-functional pseudo-peptidic reagent, and uses and applications thereof
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221743 Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
09/02/2010US20100221742 Novel cancer associated antibodies and their use in cancer diagnosis
09/02/2010US20100221737 Translocation and Mutant ROS Kinase in Human Non-Small Cell Lung Carcinoma
09/02/2010US20100221733 Biomarker of allergic disease and use of the same
09/02/2010US20100221724 Patched polypeptides and uses related thereto
09/02/2010US20100221707 Diagnostic methods for detecting congenital bone defects
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221260 Immunoglobulins
09/02/2010US20100221258 Method of treating a pathological syndrome and a pharmaceutical agent
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221256 Meningococcus adhesins nada, app and orf 40
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221254 Methods and Compositions for PDGF-C Activation and Inhibition
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221248 Directed Engagement of Activating Fc Receptors
09/02/2010US20100221222 Interferons, uses and compositions related thereto
09/02/2010US20100221212 Proproteins and methods of use thereof
09/02/2010US20100221185 Vaccines and vaccine components for inhibition of microbial cells
09/02/2010US20100221183 Peptides for treating and diagnosing cancers and methods for using the same
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010US20100221177 RS7 Antibodies
09/02/2010US20100221176 Methods and compositions for protein labelling
09/02/2010US20100221175 Antibody Therapy
09/02/2010CA2772648A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010CA2753541A1 Antibodies to troponin i and methods of use thereof
09/02/2010CA2753438A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010CA2753332A1 Antigen-binding constructs
09/02/2010CA2753287A1 Antigen-binding constructs
09/02/2010CA2753263A1 Multivalent and/or multispecific rankl-binding constructs
09/02/2010CA2751730A1 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
09/02/2010CA2744103A1 Methods for identifying immunobinders of cell-surface antigens
09/01/2010EP2224008A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
09/01/2010EP2224006A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
09/01/2010EP2224000A1 Antibody and use thereof
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223701A1 Pharmaceutical composition for cancer treatment
09/01/2010EP2222846A2 Universal fibronectin type iii binding-domain libraries
09/01/2010EP2222709A2 Antigen-binding constructs
09/01/2010EP2222708A1 Assay method for group transfer reactions
09/01/2010EP2222707A2 Anti-factor xi monoclonal antibodies and methods of use thereof
09/01/2010EP2222706A1 Antibodies against human nkg2d and uses thereof
09/01/2010EP2222705A1 Antigen binding proteins
09/01/2010EP2222704A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
09/01/2010EP2222702A1 Human monoclonal nicotine specific antibodies
09/01/2010EP2222701A2 Antibodies against influenza virus and methods of use thereof
09/01/2010EP2222700A2 Humanized anti-amyloid beta antibodies
09/01/2010EP1613347B1 Humanized antibodies that recognize beta amyloid peptide
09/01/2010EP1606409B1 Nogo receptor binding protein
09/01/2010EP1339866B1 Human testis specific serine/threonine kinase
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010EP1207905B1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
09/01/2010CN201565157U Oil and water liquid separating device
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 1494